Your browser doesn't support javascript.
loading
How did partners experience cancer patients' participation in a phase I study? An observational study after a patient's death.
Langenberg, Simone M C H; Peters, Marlies E W J; van der Graaf, Winette T A; Wymenga, Anke N Machteld; Prins, Judith B; van Herpen, Carla M L.
Afiliación
  • Langenberg SM; Department of Medical Oncology,Radboud University Medical Center,Nijmegen,The Netherlands.
  • Peters ME; Department of Medical Oncology,Radboud University Medical Center,Nijmegen,The Netherlands.
  • van der Graaf WT; Department of Medical Oncology,Radboud University Medical Center,Nijmegen,The Netherlands.
  • Wymenga AN; Department of Medical Oncology,Medisch Spectrum Twente,Enschede,The Netherlands.
  • Prins JB; Department of Medical Psychology,Radboud University Medical Center,Nijmegen,The Netherlands.
  • van Herpen CM; Department of Medical Oncology,Radboud University Medical Center,Nijmegen,The Netherlands.
Palliat Support Care ; 14(3): 241-9, 2016 06.
Article en En | MEDLINE | ID: mdl-26675215
OBJECTIVE: It can be assumed that patients' participation in a phase I study will have an important impact on their partners' life. However, evaluation of partners' experiences while patients are undergoing experimental treatment and of their well-being after the patient's death is lacking. We aimed to explore partners' experience of patients' participation in phase I studies and to investigate their well-being after a patient's death. METHOD: This was an observational study conducted after the patient's death. Partners of deceased patients who had participated in a phase I study completed a questionnaire designed by us for experience evaluation and the Beck Depression Inventory for Primary Care, the Hospital Anxiety and Depression Scale, the Inventory of Traumatic Grief, and the RAND-36 Health Survey. RESULTS: The median age of the 58 participating partners was 58 years (range: 51-65), and 67% was female. Partners reported negative effects on patients' quality of life, but only 5% of partners regretted patients' participation. Approximately two years after the patients' death, 19% of partners scored for depression, 36% for psychological distress, and 46% for complicated grief, and partners generally scored significantly lower on social and mental functioning compared to normative comparators. SIGNIFICANCE OF RESULTS: Although partners reported negative consequences on patients' quality of life, most did not regret patients' participation in the phase I studies. Prevalence of depression, psychological distress, and complicated grief seemed important problems after a patient's death, and these must be considered when shaping further support for partners of patients participating in phase I trials.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Participación del Paciente / Investigación / Ensayos Clínicos Fase I como Asunto / Esposos Tipo de estudio: Etiology_studies / Observational_studies / Qualitative_research / Risk_factors_studies Aspecto: Patient_preference Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Palliat Support Care Asunto de la revista: TERAPEUTICA Año: 2016 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Participación del Paciente / Investigación / Ensayos Clínicos Fase I como Asunto / Esposos Tipo de estudio: Etiology_studies / Observational_studies / Qualitative_research / Risk_factors_studies Aspecto: Patient_preference Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Palliat Support Care Asunto de la revista: TERAPEUTICA Año: 2016 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Reino Unido